A Novel S100 Family-Based Signature Associated with Prognosis and Immune Microenvironment in Glioma.

Yifang Hu Jiahang Song Zhen Wang Jingbao Kan Yaoqi Ge Dan Wang Rihua Zhang Wensong Zhang Yun Liu

Published in: Journal of oncology (2021)

We constructed and verified a novel S100 family-based signature associated with tumor immune microenvironment (TIME), which may shed novel light on the glioma diagnosis and treatment.

Keyphrases

stem cells